Sébastien Desprez Joins Adaptimmune as Vice President of Communications and Investor Relations
(WorldNews Health)

PHILADELPHIA and OXFORD, U.K., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that Sébastien Desprez has joined the Company as Vice President of Communications and Investor Relations. Sébastien has more than twenty years of experience in biotech and healthcare communications. He was most recently the Director of Communications at ViiV Healthcare where he developed and implemented the company`s integrated internal and external communications strategy and served as a member of the executive team. Previously, Sébastien was the Director of Communications at GSK, where he headed the communications team...